Showing results (11-20 of 40) with videos related to

Sort By:
Pageof 4
Asia-Pacific Journal of Clinical Oncology|August 18, 2012
Upfront maintenance therapy with arsenic trioxide in acute promyelocytic leukemia provides no benefit for non-t(15;17) subtypeYi-Hao Chiang, Yi-Fang Chang, Ruey-Kuen Hsieh, et al.
Planta Medica|November 20, 2012
Topoisomerase I inhibitor evodiamine acts as an antibacterial agent against drug-resistant Klebsiella pneumoniaeJui-Yu Wu, Ming-Chih Chang, Chien-Shu Chen, et al.
Cancer Reports (Hoboken, N.J.)|November 29, 2025
Daratumumab-Based Combinational Therapy as Second-Line Treatment of Relapsed-Refractory Multiple Myeloma: A Single-Center ExperienceOscar C Y Yang, Yi-Hao Chiang, Caleb Gonshen Chen, et al.
Oncology Reviews|March 13, 2019
Bortezomib therapy in a real-world setting in patients with relapsed or refractory multiple myelomaShang-Yi Huang, Tsai-Yun Chen, Ching-Yuan Kuo, et al.
Cell Death & Disease|October 2, 2020
BAFF-driven NLRP3 inflammasome activation in B cellsKen-Hong Lim, Lih-Chyang Chen, Kate Hsu, et al.
Cancer Investigation|May 29, 2007
Randomized Phase II trial of thalidomide alone versus thalidomide plus interferon alpha in patients with refractory multiple myelomaTzeon-Jye Chiou, Teng-Hsu Wang, Tsu-Yi Chao, et al.
Nutrients|April 23, 2022
Protective Effect of a Water-Soluble Carotenoid-Rich Extract of Cordyceps militaris against Light-Evoked Functional Vision Deterioration in MiceBo-Yie Chen, Ho-Shin Huang, Kan-Jen Tsai, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|January 18, 2019
Granuloma With an Underlying Lymphoma: A Diagnostic Challenge and a Wider Histologic Spectrum Including Adult T-Cell Leukemia/LymphomaChih-Ying Wu, Ren-Ching Wang, Bo-Jung Chen, et al.
Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi|March 3, 2007
An observational study on the empiric use of cefpirome in febrile neutropeniaYu Chieh Su, Yu Tsan Sheu, Ming Yieh Peng, et al.
Blood Cancer Journal|November 17, 2021
Activated naïve γδ T cells accelerate deep molecular response to BCR-ABL inhibitors in patients with chronic myeloid leukemiaYu-Cheng Chang, Yi-Hao Chiang, Kate Hsu, et al.
Pageof 4